Showing results (241-250 of 595) with videos related to
Sort By:
Pageof 60
Rheumatology (Oxford, England)|January 18, 2021
Influence of inflammatory and non-inflammatory rheumatic disorders on the clinical and biological profile of type-2 diabetesJérôme Avouac, Muriel Elhai, Marine Forien, et al.Arthritis and Rheumatism|July 20, 2011
Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cellsJérôme Avouac, Nicolas Cagnard, Jörg H Distler, et al.Rheumatology (Oxford, England)|October 4, 2023
Should complete B cell depletion be maintained in patients treated long-term with rituximab for rheumatoid arthritis?Roba Ghossan, Omar Al Tabaa, Alice Combier, et al.Arthritis & Rheumatology (Hoboken, N.J.)|August 23, 2023
Effects of B Cell Depletion by CD19-Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic SclerosisJérôme Avouac, Anne Cauvet, Cindy Orvain, et al.Arthritis Research & Therapy|April 23, 2013
Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosisJérôme Avouac, Maeva Vallucci, Vanessa Smith, et al.Journal of Scleroderma and Related Disorders|April 7, 2022
Quality of life in SSc-ILD patients: Understanding the impact of the ILD and the needs of the SSc-ILD patients and their need for caregivers in FranceYannick Allanore, Joel Constans, Dominique Godard, et al.Annals of the Rheumatic Diseases|March 11, 2016
Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosisNadira Ruzehaji, Camelia Frantz, Matthieu Ponsoye, et al.Journal of Scleroderma and Related Disorders|April 6, 2022
Patient perception of disease burden in diffuse cutaneous systemic sclerosisDinesh Khanna, Yannick Allanore, Christopher P Denton, et al.Arthritis Research & Therapy|August 31, 2018
T-cell costimulation blockade is effective in experimental digestive and lung tissue fibrosisGonçalo Boleto, Christophe Guignabert, Sonia Pezet, et al.Seminars in Arthritis and Rheumatism|November 7, 2024
Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritisOmar Al Tabaa, Sophie Hecquet, Marion Thomas, et al.Pageof 60